Total neoadjuvant therapy shows promising results for rectal cancer

Researchers in Sweden have studied a modified version of total neoadjuvant treatment (TNT) in high-risk locally advanced rectal cancer (LARC) patients. The modified treatment was as effective as the standard RAPIDO regimen, and improved neurotoxicity, despite involving older patients with more advanced tumors. The researchers stressed that their study enhances the credibility of a shortened TNT regimen in combating LARC in real-life settings.